$KORE

KORE Group Holdings, Inc.

0
0
1

No SEC Form 4 filings for $KORE in the last 30 days.

High

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.

[424B3] KORE Group Holdings, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

KORE Group Holdings, Inc. filed a prospectus supplement to update its Form S-1 with its Q1 2026 financial results, reporting $65.8M in revenue and a $(28.5M) net loss. The company also disclosed details of a Merger Agreement offering $9.25 per share in cash consideration. Key figures include $29.2M cash and restricted cash, and 17,587,851 shares outstanding as of May 6, 2026.

KORE Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KORE Group Holdings, Inc. - KORE

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of KORE Group Holdings, Inc. (NYSE: KORE) to Searchlight Capital Partners, L.P. and Abry Partners. The firm is examining whether the proposed cash consideration of $9.25 per share for KORE shareholders adequately values the company. KSF invites KORE shareholders who believe the transaction undervalues the company to contact them to discuss their legal rights.